Home › COPD › Texas › San Antonio
COPD clinical trials in San Antonio, TX
3 studies for COPD are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Discovery Clinical Trials - San Antonio- Site Number : 8400031, San Antonio
- Bandera Family Health Care - San Antonio- Site Number : 8400021, San Antonio
- Element Research Group- Site Number : 8400115, San Antonio
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RecruitingPhase 3
- Research Site, San Antonio
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RecruitingPhase 3
- GSK Investigational Site, San Antonio
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA22 studies
- Miami, FL18 studies
- Birmingham, AL18 studies
- Boston, MA17 studies
- Houston, TX15 studies
- Orlando, FL15 studies
- Chicago, IL14 studies
- Pittsburgh, PA13 studies
- Baltimore, MD13 studies
- Dallas, TX12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Breast Cancer46 studies
- Colorectal Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity39 studies
- Type 2 Diabetes36 studies
- Overweight33 studies
- Pancreatic Cancer31 studies
- Ovarian Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.